Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for SOPHiA GENETICS SA (SOPH : NSDQ)
 
 • Company Description   
SOPHiA GENETICS SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM(TM) Platform, a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. SOPHiA GENETICS SA is based in BOSTON.

Number of Employees: 423

 
 • Price / Volume Information   
Yesterday's Closing Price: $2.99 Daily Weekly Monthly
20 Day Moving Average: 167,230 shares
Shares Outstanding: 66.69 (millions)
Market Capitalization: $199.39 (millions)
Beta: 1.00
52 Week High: $4.92
52 Week Low: $2.58
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -4.47% -8.72%
12 Week 3.82% -11.32%
Year To Date -2.61% -8.77%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
LA PIECE CH-1180
-
ROLLE,V8 00000
CHE
ph: 41-21-694-1060
fax: -
None http://www.sophiagenetics.com
 
 • General Corporate Information   
Officers
Jurgi Camblong - Chief Executive Officer
Troy Cox - Chairman
Ross Muken - President
George Cardoza - Chief Financial Officer
Tomer Berkovitz - Director

Peer Information
SOPHiA GENETICS SA (HLIS)
SOPHiA GENETICS SA (AZTA)
SOPHiA GENETICS SA (APYI)
SOPHiA GENETICS SA (RNVA)
SOPHiA GENETICS SA (HMSY)
SOPHiA GENETICS SA (LRSI)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MEDICAL INFO SYS
Sector: Medical
CUSIP: H82027105
SIC: 7374
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 08/05/25
Share - Related Items
Shares Outstanding: 66.69
Most Recent Split Date: (:1)
Beta: 1.00
Market Capitalization: $199.39 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/05/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 2.33
Price/Cash Flow: -
Price / Sales: 2.97
EPS Growth
vs. Year Ago Period: -23.81%
vs. Previous Quarter: -13.04%
Sales Growth
vs. Year Ago Period: 12.68%
vs. Previous Quarter: 0.26%
ROE
06/30/25 - -
03/31/25 - -63.47
12/31/24 - -53.91
ROA
06/30/25 - -
03/31/25 - -40.06
12/31/24 - -36.01
Current Ratio
06/30/25 - -
03/31/25 - 3.11
12/31/24 - 3.71
Quick Ratio
06/30/25 - -
03/31/25 - 2.94
12/31/24 - 3.49
Operating Margin
06/30/25 - -
03/31/25 - -98.51
12/31/24 - -95.89
Net Margin
06/30/25 - -
03/31/25 - -98.51
12/31/24 - -95.89
Pre-Tax Margin
06/30/25 - -
03/31/25 - -96.41
12/31/24 - -94.01
Book Value
06/30/25 - -
03/31/25 - 1.28
12/31/24 - 1.48
Inventory Turnover
06/30/25 - -
03/31/25 - 3.58
12/31/24 - 3.41
Debt-to-Equity
06/30/25 - -
03/31/25 - 0.16
12/31/24 - 0.14
Debt-to-Capital
06/30/25 - -
03/31/25 - 13.46
12/31/24 - 12.06
 

Powered by Zacks Investment Research ©